144 related articles for article (PubMed ID: 34568314)
1. Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway.
Liang S; Zhou X; Cai D; Rodrigues-Lima F; Chi J; Wang L
Front Cell Dev Biol; 2021; 9():685954. PubMed ID: 34568314
[TBL] [Abstract][Full Text] [Related]
2. Chidamide Inhibits Cell Proliferation via the PI3K/AKT Pathway in K562 Cells Based on Network Pharmacology and Experimental Validation.
Liang S; Zhou X; Cai D; Rodrigues-Lima F; Wang L
Curr Pharm Des; 2021; 27(26):2990-2998. PubMed ID: 34218775
[TBL] [Abstract][Full Text] [Related]
3. Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.
Zhao S; Guo J; Zhao Y; Fei C; Zheng Q; Li X; Chang C
Am J Transl Res; 2016; 8(7):3169-78. PubMed ID: 27508038
[TBL] [Abstract][Full Text] [Related]
4. Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.
Mao J; Li S; Zhao H; Zhu Y; Hong M; Zhu H; Qian S; Li J
Am J Transl Res; 2018; 10(8):2567-2578. PubMed ID: 30210693
[TBL] [Abstract][Full Text] [Related]
5. Chidamide shows synergistic cytotoxicity with cytarabine via inducing G0/G1 arrest and apoptosis in myelodysplastic syndromes.
Liu Z; Chen J; Wang H; Ding K; Li Y; de Silva A; Sehgal V; Burbano JL; Sundararaj R; Gamage J; Audu V; Fu R
Am J Transl Res; 2017; 9(12):5631-5642. PubMed ID: 29312515
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation
Zhan Z; Liu Z; Zhang C; Gao H; Lai J; Chen Y; Huang H
Front Pharmacol; 2022; 13():967141. PubMed ID: 36133816
[No Abstract] [Full Text] [Related]
7. Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.
Wang H; Liu YC; Zhu CY; Yan F; Wang MZ; Chen XS; Wang XK; Pang BX; Li YH; Liu DH; Gao CJ; Liu SJ; Dou LP
J Exp Clin Cancer Res; 2020 Dec; 39(1):278. PubMed ID: 33298132
[TBL] [Abstract][Full Text] [Related]
8. A combination of low-dose decitabine and chidamide resulted in synergistic effects on the proliferation and apoptosis of human myeloid leukemia cell lines.
Xu F; Guo H; Shi M; Liu S; Wei M; Sun K; Chen Y
Am J Transl Res; 2019; 11(12):7644-7655. PubMed ID: 31934307
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanism.
Li G; Li D; Yuan F; Cheng C; Chen L; Wei X
Ann Transl Med; 2021 Oct; 9(20):1575. PubMed ID: 34790781
[TBL] [Abstract][Full Text] [Related]
10. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
12. Effects of Qinghuang Powder on Acute Myeloid Leukemia Based on Network Pharmacology, Molecular Docking, and In Vitro Experiments.
Zeng YJ; Wu M; Zhang H; Wu XP; Zhou L; Wan N; Wu ZH
Evid Based Complement Alternat Med; 2021; 2021():6195174. PubMed ID: 34992668
[TBL] [Abstract][Full Text] [Related]
13. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.
Liu Z; Ding K; Li L; Liu H; Wang Y; Liu C; Fu R
Biomed Pharmacother; 2016 Oct; 83():1032-1037. PubMed ID: 27541047
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
Jiang X; Jiang L; Cheng J; Chen F; Ni J; Yin C; Wang Q; Wang Z; Fang D; Yi Z; Yu G; Zhong Q; Carter BZ; Meng F
J Transl Med; 2021 Mar; 19(1):117. PubMed ID: 33743723
[TBL] [Abstract][Full Text] [Related]
15. Combination of betulinic acid and chidamide inhibits acute myeloid leukemia by suppression of the HIF1α pathway and generation of reactive oxygen species.
Zhang H; Li L; Li M; Huang X; Xie W; Xiang W; Yao P
Oncotarget; 2017 Nov; 8(55):94743-94758. PubMed ID: 29212263
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Approach Based on Network Pharmacology Combined with Experimental Verification Reveals AMPK/PI3K/Akt Signaling is an Important Way for the Anti-Type 2 Diabetic Activity of Silkworm Excrement.
Duan H; Zhang Q; Liu J; Li R; Peng W; Wu C
Diabetes Metab Syndr Obes; 2021; 14():601-616. PubMed ID: 33603425
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin 1 inhibits the apoptosis of human trophoblasts by activating the PI3K/Akt signaling pathway.
Ji J; Chen L; Zhuang Y; Han Y; Tang W; Xia F
Int J Mol Med; 2020 Nov; 46(5):1908-1922. PubMed ID: 33000176
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
20. Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway.
Lin L; Que Y; Lu P; Li H; Xiao M; Zhu X; Li D
Front Pharmacol; 2020; 11():569651. PubMed ID: 33192510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
